Humoral Response After Two Doses of COVISHIELD Vaccine in Patients Undergoing Maintenance Hemodialysis.

Journal: The Journal of the Association of Physicians of India
PMID: 38700302

Abstract

OBJECTIVES: Maintenance hemodialysis (MHD) patients are at increased risk of contracting coronavirus disease 2019 (COVID-19). Vaccine against COVID-19 offers the benefit of protection from severe illness. In this study, we assessed the humoral response after two doses of the COVISHIELD vaccine in MHD patients.

Authors

  • Manish R Balwani
    Consultant, Department of Nephrology, Saraswati Kidney Care Center, Nagpur, and JNMC, Sawangi, Wardha, Maharashtra, India, Corresponding Author.
  • Amit S Pasari
    Consultant, Department of Nephrology, Saraswati Kidney Care Center, Nagpur, and JNMC, Sawangi, Wardha, Maharashtra, India.
  • Charulata Bawankule
    Consultant, Department of Nephrology, All India Institute of Medical Sciences (AIIMS), Nagpur, India.
  • Amol Bhawane
    Assistant Professor, Department of Nephrology, All India Institute of Medical Sciences (AIIMS), Nagpur, India.
  • Priyanka Tolani
    Assistant Professor, Department of Internal Medicine, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India.
  • Vijay M Katekhaye
    Department of Clinical Research, Saraswati Kidney Care Center, Nagpur, Maharashtra, India.

Keywords

External Resources

Popular Topics
Recent Journals